RSV maternal vaccine cuts baby hospital admissions by up to 85%

• RSV maternal vaccination during pregnancy reduces hospital admissions in infants by up to 85%, with largest protective effect in premature babies, according to England-based real-world evidence
• Study findings support current JCVI recommendations for routine RSV vaccination in pregnancy as effective strategy for preventing severe lower respiratory tract infection in vulnerable neonatal populations
• Clinicians should discuss RSV maternal vaccination with pregnant patients, particularly those at higher risk of premature delivery, to provide neonatal protection without requiring infant immunisation

Largest real-world study in England confirms premature infants protected by vaccination.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.